United Therapeutics Corp. (UTHR) climbed for the bulk of Tuesday's session and finished with a gain of 12.78 at $150.03. United Therapeutics rose past the upper end of over a 2-week trading range Tuesday and set a 9-month high.
United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $111.09 to a high of $114.10. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $114.01 on volume of 132,000 …
On Tuesday, shares in Dublin, Ireland-based Amarin Corp. PLC recorded a trading volume of 1.78 million shares. The stock ended at $3.75, rising 2.18% from the last trading session. The Company's shares have gained 7.76% in the last …
On Tuesday, shares in Dublin, Ireland-based Amarin Corp. PLC recorded a trading volume of 1.78 million shares. The …
KAIT2mon
Given up for dead just weeks ago the biotech sector is suddenly back with a vengeance. Seemingly everyone’s favorite …
At that time, the company had said that there would be a higher frequency of blood cell count monitoring in the phase III …
United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $111.09 to a high of $114.10. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $114.01 on volume of 132,000 …
Description: United Therapeutics develops and makes medicines for cardiovascular conditions, cancer and infectious diseases. Developments: Executives at United Therapeutics are hoping this year will be as good as 2004. Last year the …
Spark is a Zacks Rank #3 (Hold) stock - you can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The NASDAQ Biotechnology Index gained 3.1% over the last four trading sessions. Among major biotech stocks, …